Scientific Publications
CYB003
American College of Neuropsychopharmacology Annual Meeting – December 4-7, 2022
Poster #P361: In Vitro and in Vivo Profile of CYB003: A Novel, Deuterated Psilocybin Analog for the Potential Treatment of Major Depressive Disorder
ACNP 61st Annual Meeting: Poster Abstracts P271-P540. Neuropsychopharmacol. 47 (Suppl 1), 220–370 (2022).
Read the Abstract
View the Poster
Poster #P362: Pharmacokinetic Profile of CYB003: A Novel, Deuterated Psilocybin Analog for the Potential Treatment of Major Depressive Disorder
ACNP 61st Annual Meeting: Poster Abstracts P271-P540. Neuropsychopharmacol. 47 (Suppl 1), 220–370 (2022).
Read the Abstract
View the Poster
Society for Neuroscience – November 12-16, 2022
Pharmacological and Pharmacokinetic Profile of CYB003, A Novel, Orally Active Analog of Psilocybin for the Potential Treatment of Major Depressive Disorder
View the Poster
From Research to Reality:
Global Summit on Psychedelic-Assisted Therapies and Medicine – May 27-29, 2022
Pharmacological and Pharmacokinetic Profile of CYB003, A Novel, Orally Active Analog of Psilocybin
View the Poster
CYB003
American College of Neuropsychopharmacology Annual Meeting – December 4-7, 2022
Poster #P361: In Vitro and in Vivo Profile of CYB003: A Novel, Deuterated Psilocybin Analog for the Potential Treatment of Major Depressive Disorder
ACNP 61st Annual Meeting: Poster Abstracts P271-P540. Neuropsychopharmacol. 47 (Suppl 1), 220–370 (2022).
Read the Abstract
View the Poster
Poster #P362: Pharmacokinetic Profile of CYB003: A Novel, Deuterated Psilocybin Analog for the Potential Treatment of Major Depressive Disorder
ACNP 61st Annual Meeting: Poster Abstracts P271-P540. Neuropsychopharmacol. 47 (Suppl 1), 220–370 (2022).
Read the Abstract
View the Poster
Society for Neuroscience – November 12-16, 2022
Pharmacological and Pharmacokinetic Profile of CYB003, A Novel, Orally Active Analog of Psilocybin for the Potential Treatment of Major Depressive Disorder
View the Poster
From Research to Reality:
Global Summit on Psychedelic-Assisted Therapies and Medicine – May 27-29, 2022
Pharmacological and Pharmacokinetic Profile of CYB003, A Novel, Orally Active Analog of Psilocybin
View the Poster
EMBARK
Brennan, W. and Belser, A.B. (2022). Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. Frontiers in Psychology 13:866018.
Read More
EMBARK
Brennan, W. and Belser, A.B. (2022). Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model. Frontiers in Psychology 13:866018.
Read More
